San Diego, CA -- (SBWIRE) -- 12/19/2017 -- The Shareholders Foundation announces that an investor, who purchased shares of OvaScience Inc (NASDAQ:OVAS) , filed a lawsuit over alleged violations of Sections 11, 12(a), and 15 of the Securities Act of 1933 in connection with in the Company's January 8, 2015 Secondary Offering.

Investors who purchased shares of OvaScience Inc (NASDAQ:OVAS) in the Company's January 8, 2015 Secondary Offering have certain options and for certain investors are short and strict deadlines running. Deadline: January 22, 2018. NASDAQ:OVAS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The plaintiff alleges that the Defendants violated provisions of the Securities Act by issuing false and misleading statements to investors, including in filings with the U.S. Securities and Exchange Commission ("SEC"). More specifically, the plaintiff claims that the Defendants made false and/or misleading statements and/or failed to disclose that the very science behind AUGMENT was untested and in doubt, that the patients that had received OvaScience's AUGMENT procedure in 2014 did not achieve a pregnancy success rate that was significantly higher than the rate achieved without the Company's AUGMENT procedure, that the Company had not chosen to undertake its studies outside of the United States, but was forced to as it did not want to meet stringent and expensive federal regulations, and that the Company was far from being profitable, or even approaching profitability.

Those who purchased shares of OvaScience Inc (NASDAQ:OVAS) ) in the Company's January 8, 2015 Secondary Offering, have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com